Your browser doesn't support javascript.
loading
Toll-like receptor 3 (TLR3) variant and NLRP12 mutation confer susceptibility to a complex clinical presentation.
Tal, Yuval; Ribak, Yaarit; Khalaila, Aya; Shamriz, Oded; Marcus, Nofar; Zinger, Adar; Meiner, Vardiella; Schuster, Ronen; Lewis, Eli C; Nahum, Amit.
Afiliação
  • Tal Y; Allergy and Clinical immunology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Internal Medicine Division, Hadassah-Hebrew University Medical Center, Ein Kerem, Jerusalem, Israel. Electronic address: yuvalt@hadassah.org.il.
  • Ribak Y; Allergy and Clinical immunology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Internal Medicine Division, Hadassah-Hebrew University Medical Center, Ein Kerem, Jerusalem, Israel.
  • Khalaila A; Pediatrics Department A, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Shamriz O; Allergy and Clinical immunology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
  • Marcus N; Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
  • Zinger A; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel; Institute of Gastroenterology and Liver Diseases, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Meiner V; Department of Human Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Schuster R; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Lewis EC; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Nahum A; Pediatrics Department A, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Clin Immunol ; 212: 108249, 2020 03.
Article em En | MEDLINE | ID: mdl-31445170
Genetic aberrations in the toll-like receptor (TLR)3 pathway are associated with increased susceptibility to herpes simplex virus (HSV) infections. Leucine-rich repeat and PYD-containing protein (NLRP)12 is a component of the inflammasome apparatus, which is critical to an immediate innate inflammatory response. Aberrations in NLRP12 have been shown to mediate auto-inflammation. In this study, we present a 44-year old patient with severe HSV esophagitis and Crohn's disease. An immune and genetic investigation confirmed two coinciding genetic mutations in TLR3 and NLRP12. Our findings support conducting laboratory workup that targets TLR3 pathway in the immunocompetent host developing recurrent HSV infections.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Peptídeos e Proteínas de Sinalização Intracelular / Esofagite / Receptor 3 Toll-Like / Herpes Simples Limite: Adult / Female / Humans Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Peptídeos e Proteínas de Sinalização Intracelular / Esofagite / Receptor 3 Toll-Like / Herpes Simples Limite: Adult / Female / Humans Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article